Welcome to our dedicated page for Bio Green Med Solution SEC filings (Ticker: BGMS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bio Green Med Solution's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bio Green Med Solution's regulatory disclosures and financial reporting.
FITTERS Diversified Berhad reported beneficial ownership of 699,158 shares of Bio Green Med Solution, Inc. That holding represents 19.99% of the company's common stock and is reported as held with sole voting and sole dispositive power over those shares. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filer is organized in Malaysia and provided Malaysian addresses for both the issuer's principal office and the filer.
FITTERS Diversified Berhad reported initial beneficial ownership of 699,158 shares of Bio Green Med Solution, Inc. (BGMS) common stock on a Form 3 filed after an exchange agreement dated May 6, 2025 that closed on September 12, 2025. The filing lists FITTERS as a director of the issuer and states the shares are held directly. The Form 3 is signed by Datuk Tan Chor How Christopher on September 16, 2025. No derivative securities, option grants, or additional terms are disclosed in the filing.
FAQ
What is the current stock price of Bio Green Med Solution (BGMS)?
What is the market cap of Bio Green Med Solution (BGMS)?
